In 5 patients additional variants were identified in other genes through next generation sequencing, including a potentially pathogenic variant in MYBPC3 in patient 29 [36] and a variant in RYR1 previously associated with the malignant hyperthermia (MH) susceptibility trait in patient 1. Here, MYBPC3 is linked to Malignant hyperthermia.